Warning: Declaration of subscribe2_widget::addPluginSubMenu() should be compatible with mijnpress_plugin_framework::addPluginSubMenu($title, $function, $file, $capability = 10, $where = 'plugins.ph...') in /data/32/2/10/97/2499423/user/2737425/htdocs/wordpress1/wp-content/plugins/subscribe2-widget/subscribe2-widget.php on line 18

Warning: Declaration of subscribe2_widget::addPluginContent($links, $file) should be compatible with mijnpress_plugin_framework::addPluginContent($filename, $links, $file, $config_url = NULL) in /data/32/2/10/97/2499423/user/2737425/htdocs/wordpress1/wp-content/plugins/subscribe2-widget/subscribe2-widget.php on line 18
Gabrielle | SEBIO

Institute for Commercialization of Florida Technology Delivers Nearly $1.9 Billion Economic Impact

Posted by on Nov 4, 2019 in Newsroom | 0 comments

Boca Raton, FL – The Institute for Commercialization of Florida Technology (the Institute) announced today results of a new study conducted by The Washington Economics Group, Inc.® (WEG), a Coral Gables-based boutique economic consulting firm led by nationally recognized business economist Dr. J. Antonio (Tony) Villamil. The study measured economic impacts of the Institute during FY 2018-19 to update prior years’ studies and concluded that the organization’s impact increased nearly 19% as funded companies continue to raise investment capital, increase sales, create jobs, and bring...

Read More

Meet the company that won $10,000 at BioPitch

Posted by on Nov 4, 2019 in Newsroom | 0 comments

ImmunSYS, a Fort Lauderdale company developing technology to treat prostate cancer and other solid tumors, was the top winner in BioPitch, a Shark Tank for life science companies that highlighted the 2019 BioFlorida annual conference. The company won $10,000 after besting 15 other seed-stage and early-stage life science firms that also pitched at the Oct. 22 conference in Tampa. More than 20 investor judges worked over the past several months to review a record-breaking number of applications for BioPitch, and they determined the 16 semi-finalists who presented at the conference, said...

Read More

One Week To Go – SEBIO Investor & Partnering Forum Returns to Florida

Posted by on Oct 29, 2019 in Newsroom | 0 comments

Kicking off 24-hours of prime networking, relationship-building, and education, the Southeast BIO Investor & Partnering Forum returns to South Florida November 6-7, 2019 at the historic Biltmore Hotel in Coral Gables, Florida. Register today to take advantage of reduced rates. Dozens of investors are registered and committed to attend including representatives from: Aisling Capital,  Amgen Ventures,  Abbvie Ventures, MRL Ventures (Merck), Johnson & Johnson Development Corp., Osage University Partners, Baird Capital, Hatteras Venture Partners, Pappas Capital, Medicxi...

Read More

Early Stage Emerging Biotech, Pharma, & Medical Device Companies Announced

Posted by on Oct 23, 2019 in Newsroom, SEBIO News | 0 comments

Innovative drug therapies, advanced medical devices, diagnostics, and other cutting-edge healthcare technologies from throughout the Southeast will be showcased November 6-7 at the Southeast BIO Investor & Partnering Forum at the historic Biltmore Hotel in Coral Gables, Florida. Innovative drug therapies, advanced medical devices, diagnostics, and other cutting-edge healthcare technologies from throughout the Southeast will be showcased November 6-7 at the Southeast BIO Investor & Partnering Forum at the historic Biltmore Hotel in Coral Gables, Florida. Register...

Read More

Three Weeks Remain – Register Today

Posted by on Oct 16, 2019 in Newsroom, SEBIO News | 0 comments

Kicking off 24-hours of prime networking, relationship-building, and education, the Southeast BIO Investor & Partnering Forum returns to South Florida November 6-7, 2019 at the historic Biltmore Hotel in Coral Gables, Florida. Among the Forum highlights will be the keynote address from Dennis Purcell. Mr. Purcell is the original Founder of Aisling Capital LLC and currently serves as a Senior Advisor to Aisling. Previously, he served as the Senior Managing Partner. Prior to Aisling Capital, Mr. Purcell served as Managing Director of the Life Sciences Investment Banking Group at...

Read More